The world's largest chemicals company, BASF SE (BAS.XE) of Germany, Tuesday became the latest to target expansion in the Asia-Pacific region...
The sale of its cash-cow pharma unit leaves Belgium's Solvay SA (SOLB.BT) a pure chemicals and plastics player that wants to reinvent itself by...
(Adds comments from credit-ratings firms, updates share price, in the fifth through seventh paragraphs.) By Jon Kamp Of DOW JONES NEWSWIRES Abbott...
By Jon Kamp Of DOW JONES NEWSWIRES Abbott Laboratories' (ABT) $6.6 billion purchase of Solvay SA's (SVYSY) drug business continues a busy stretch...
By Peter Loftus Of DOW JONES NEWSWIRES When Abbott Laboratories' (ABT) top product, the arthritis drug Humira, dropped in status from from wildly...
Chemical and pharmaceutical company Solvay SA (SOLB.BT) confirmed Monday it's selling its drug making activities' Abbott Laboratories (ABT) for...
Belgian chemical and pharmaceutical company Solvay SA (SOLB.BT) is unlikely to announce any new acquisition before closing the sale of its pharma...
Chemical and pharmaceutical company Solvay SA (SOLB.BT) confirmed Monday it is selling its drug making activities to U.S. rival Abbott...
Belgium's Solvay SA (SOLB.BT) confirmed Monday it is selling its pharmaceutical activities to U.S. rival Abbott Laboratories (ABT) for about...
Diversifies Abbott's pharmaceutical products, expanding international growth platform Supports long-term strategy to bolster presence in key...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.